Period of involvement: Since 2020 - current

Client: Vaxxas Pty Ltd

VenturePro has assisted Vaxxas on multiple business cases to State and Commonwealth Government agencies for manufacturing and business support for the commercialisation of their novel vaccination technology. We worked with Vaxxas to prepare the business case to establish their new manufacturing facility at Northshore Hamilton which opened in March 2023.

Key outcomes achieved: Whilst the amount of funding received is confidential, with the help of VenturePro, Vaxxas has received significant non-dilutive cash and in-kind funding support.